pegvaliase-pqpz

FDA Drug Profile — Palynziq

Drug Details

Generic Name
pegvaliase-pqpz
Brand Names
Palynziq
Application Number
BLA761079
Sponsor
BioMarin Pharmaceutical Inc.
NDC Codes
5
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
PEGVALIASE

Indications and Usage

1 INDICATIONS AND USAGE PALYNZIQ is indicated to reduce blood phenylalanine concentrations in adult and pediatric patients 12 years of age and older with phenylketonuria (PKU) who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management. PALYNZIQ is a phenylalanine (Phe)-metabolizing enzyme indicated to reduce blood phenylalanine concentrations in adult and pediatric patients 12 years of age and older with phenylketonuria (PKU) who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management. ( 1 )